References
- Tosca MA, Schiavetti I, Duse M, Marseglia GL, Ciprandi G. A survey on the management of children with asthma in primary care setting in Italy. Pediatr Allergy Immunol Pulmonol. 2021;34(2):39–42.
- Global Initiative for Asthma. GINA guidelines. Global Strategy for Asthma Management and Prevention. 2021. [accessed July 2021]. http://www.ginasthma.org/.
- Gaillard EA, Kuehni CE, Turner S, Goutaki M, Holden KA, de Jong CCM, Lex C, Lo DKH, Lucas JS, Midulla F, et al. European Respiratory Society clinical practice guidelines for the diagnosis of asthma in children aged 5-16 years. Eur Respir J. 2021:2004173. doi:https://doi.org/10.1183/13993003.04173-2020.
- Mallol J, Riquelme C, Aguirre V, Martínez M, Gallardo A, Sánchez C, Córdova P. Value of bronchial reversibility to salbutamol, exhaled nitric oxide and responsiveness to methacholine to corroborate the diagnosis of asthma in children. Allergol Immunopathol (Madr). 2020;48(3):214–222. doi:https://doi.org/10.1016/j.aller.2019.11.001.
- Hopp RJ, Pasha MA. A literature review of the evidence that a 12% improvement in FEV1 is an appropriate cut-off for children. J Asthma. 2016;53(4):413–418. doi:https://doi.org/10.3109/02770903.2015.1108436.
- Galant SP, Morphew T, Amaro S, Liao O. Value of the bronchodilator response in assessing controller naïve asthmatic children. J Pediatr. 2007;151(5):457–462. doi:https://doi.org/10.1016/j.jpeds.2007.05.004.
- Dundas I, Chan EY, Bridge PD, McKenzie SA. Diagnostic accuracy of bronchodilator responsiveness in wheezy children. Thorax. 2005;60(1):13–16. doi:https://doi.org/10.1136/thx.2004.029934.
- Stanford RH, Shah MB, D’Souza AO, Dhamane AD, Schatz M. Short-acting β-agonist use and its ability to predict future asthma-related outcomes. Ann Allergy Asthma Immunol. 2012;109(6):403–407. doi:https://doi.org/10.1016/j.anai.2012.08.014.
- Tantisira K, Fuhlbrigge A, Tonascia J, Vannatta M, Zeiger R, Strunk R, Szefler S, Weiss S. Bronchodilation and bronchoconstriction: predictors of future lung function in childhood asthma. J Allergy Clin Immunol. 2006;117(6):1264–1271. doi:https://doi.org/10.1016/j.jaci.2006.01.050.
- de Jong CCM, Pedersen ESL, Mozun R, Goutaki M, Trachsel D, Barben J. Diagnosis of asthma in children: the contribution of a detailed history and test results. Eur Respir J. 2019;54:1901326. doi:https://doi.org/10.1183/13993003.01326-2019.
- Hopp RJ, Wilson M, Pasha MA. A compendium and review of pediatric pulmonary function testing assessment opportunities for asthma. J Asthma. 2021:1–6. doi:https://doi.org/10.1080/02770903.2021.1941094.
- Guezguez F, Knaz H, Anane I, Bougrida M, Ben Saad H. The ‘clinically significant’ bronchodilator responsiveness (BDR) in children: a comparative study between six definitions of scholarly societies and a mini-review. Expert Rev Respir Med. 2021;15(6):823–832. doi:https://doi.org/10.1080/17476348.2021.1906653.
- Berrier A, Tiotiu A, Bonabel C, Richard D, Nguyen-Thi PL, Demoulin-Alexikova S, Schweitzer C, Ioan I. Assessment of bronchial obstruction and its reversibility by shape indexes of the flow-volume loop in asthmatic children . Pediatr Pulmonol. 2021;56(1):226–233. doi:https://doi.org/10.1002/ppul.25162.
- Tosca MA, Marseglia GL, Ciprandi G. The real-world "ControL’Asma" study: a nationwide taskforce on asthma control in children and adolescents. Allergol Immunopathol (Madr). 2021;49(1):32–39. doi:https://doi.org/10.15586/aei.v49i1.14.